… The objective of this review is to evaluate whether the preventive use of clotting factor
concentrates in people with hemophilia A or B improves short‐ and long‐term outcomes as …

… The objective of this review is to evaluate whether the preventive use of clotting factor
concentrate in people with hemophilia A or B improves short‐ and long‐term outcomes as …

… We compared intravenous clotting factor concentrates administered as prophylactic
treatment in any formulation (eg fresh frozen plasma, cryoprecipitate, lyophilised plasma‐derived …

… protocol for a review on haemophilia in the Cochrane Database. … 'Clotting factor concentrates
given to prevent bleeding and bleeding-related complications in people with haemophilia A …

… of common congenital bleeding disorders, their complications, and … Replacement clotting
factor concentrates should not be … on the clear history of a bleeding-related problem, not the …

… administration of a concentrate of the deficient clotting factor. … designed to reduce or prevent
long-term complications through the … with hospitalization for bleeding-related complications. …

… of regular infusion of factor concentrates to prevent bleeding and resulting … bleeding-related
complications in people with hemophilia A … of clotting factor concentrate to prevent bleeding). …

… factor concentrates in patients with hemophilia A and B [1] has … was conceived to prevent
bleeding and joint damage by … the use of prophylactic clotting factor is effective in decreasing …

… basis with the intent of preventing bleeding, especially hemarthroses, a particularly disabling
bleeding-related complication in PWH. Administration of factor concentrates before, during, …

… to optimize prophylaxis with clotting factor concentrates. This paper, … Clotting factor concentrates
given to prevent bleeding and bleeding‐related complications in people with hemophilia …